EMCDDA Home
  • EN
Search

Figure INF-9. Prevalence of markers of HBV infection among injecting drug users: studies with national and sub-national coverage

Part (ii) Percentage with current infection (positive for HBsAg), 2010–11

 
 
CountryyearNationalSub-national
Related links:
Hungary20110.51.6
Cyprus20110.7
Germany 20110.31.5
Norway20111.2
Croatia20102.4
Greece 20113.81.21.12.91.04.21.82.70.00.00.00.05.43.19.24.0
Portugal2010/20114.32.2
Belgium20113.74.3
Bulgaria20114.5
Austria20115.7
Latvia20116.2
Netherlands2010/20110.013
Poland
Romania
Sweden
Czech Republic
Denmark
Estonia
Ireland
Spain
France
Italy
Luxembourg
Malta
Slovenia
Slovakia
Finland
Lithuania
United Kingdom
Turkey
http://www.emcdda.europa.eu/stats13/inffig9b: Figure INF-09 part (i)
For primary sources, study details and data before 2010, see Table INF-114 and Table INF-0.
See also 'General notes for interpreting data' on the Explanatory notes and help page

Notes:

Dark squares are samples with national coverage; blue triangle are samples with sub-national (including local or regional) coverage.

Differences between countries have to be interpreted with caution owing to different types of settings and/or study methods; national sampling strategies vary.

Countries are presented by order of increasing prevalence, based on the average of national data or, if not available, of sub-national data.

Sources:

Reitox Network

Country Hungary Cyprus Germany  Norway Croatia Greece  Portugal Belgium Bulgaria Austria Estonia Latvia Netherlands
National 0.5 0.7       3.8 4.3            
National           1.2 2.2            
                           
Subnational 1.6   0.3 1.2 2.4 1.1   3.7 4.5 5.7 5.7 6.2 13
Subnational      1.5     2.9   4.3          
 Subnational           1              
 Subnational           4.2              
 Subnational           1.8              
 Subnational           2.7              
 Subnational           0              
 Subnational           0              
 Subnational           0              
 Subnational           0              
 Subnational           5.4              
 Subnational           3.1              
 Subnational           9.2              
 Subnational           4              

inffig9b

 

About the EMCDDA

The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) is the reference point on drugs and drug addiction information in Europe. Inaugurated in Lisbon in 1995, it is one of the EU's decentralised agencies. Read more >>

Contact us

EMCDDA
Praça Europa 1, Cais do Sodré
1249-289 Lisbon
Portugal
Tel. (351) 211 21 02 00
Fax (351) 218 13 17 11

More contact options >>

Page last updated: Monday, 23 November 2015